Delivery Order SPE2DB22D7065-SPE2DB26FH0NU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,526.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract for pharmaceutical supply. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $17,952.65 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a $47,009.04 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's place of business in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $14,595.53 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a $27,537.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on April 23, 2025, with completion scheduled for April 24, 2025. This non-compete delivery order represents a pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $21,198.66 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of pharmaceutical supply support to federal healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $36,944.08 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, competitively awarded delivery order represents a direct fulfillment under the company's existing pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors valued at $1,801.51, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The order will be fulfilled from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,974.69 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL pen injectors on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $10,875.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on October 28, 2025, with an ultimate completion date of October 29, 2025. This contract utilizes a firm fixed price structure and was competitively awarded without any set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB26FH0NUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL pen injectors on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical contract vehicle enables comprehensive global pharmaceutical support for military healthcare programs and serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, as a major pharmaceutical distributor, supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through this strategic contracting relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/4/25 |